From L to R: Raghu Kalluri, Padmanee Sharma and Jim Allison (Allison Institute)
Jim Allison launches new institute aimed at speeding drug development and raising 'survival curve for all cancers'
Jim Allison’s name is linked to a 2018 Nobel Prize, the immune system-activating cancer med Yervoy and a host of accolades across his multi …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
